CCNA2 expression was lower in metastases relative to that in matched primary colon adenocarcinoma, suggesting that CCNA2 negatively controlled motility by promoting RhoA activation, thereby showing a new function of CCNA2 in cytoskeletal rearrangement and cell migration (39). This evidence concerns the gene CCNA2 and colon adenocarcinoma.